Document 0074 DOCN M9580074 TI Synthesis, absolute configuration, and enantioselectivity of antiretroviral effect of (R)-(-)- and (S)-(+)-cytallene. Lipase-catalyzed enantioselective acylations of (+/-)-N4-acylcytallenes. DT 9506 AU Jones BC; Silverton JV; Simons C; Megati S; Nishimura H; Maeda Y; Mitsuya H; Zemlicka J; Department of Chemistry, Michigan Cancer Foundation, Wayne State; University School of Medicine, Detroit 48201, USA. SO J Med Chem. 1995 Apr 14;38(8):1397-405. Unique Identifier : AIDSLINE MED/95248521 AB Enantioselectivity of acylations of (+/-)-cytallene (1b), (+/-)-N4-acetylcytallene (11a), (+/-)-N4-benzoylcytallene (11b), and (+/-)-N4-(9-fluorenylmethoxycarbonyl)cytallene (11c) using vinyl butyrate or acetate catalyzed by lipases in organic solvents was investigated. Reactions with 1b, 11a, and adenallene (1a) did not display a high enantioselectivity but all resulted in a predominant acylation of the (-)-enantiomers. Application of the Lowe-Brewster rule led to a tentative assignment of the R-configuration to all acylated products. Studies of the time course of acylation of (+/-)-N4-benzoylcytallene (11b) in chloroform, tetrahydrofuran (THF), tetrahydropyran (THP), tetrahydrothiophene (THT), and dioxane with lipase PS30 and/or AK showed that the reaction in THF catalyzed by lipase AK was the most promising for resolution of 11b. Indeed, a large-scale acylation afforded, after separation and deprotection of intermediates 3e and 10d, (+)- and (-)-cytallene (3c and 2b) in high yield and enantioselectivity. Acylation of 11c in THF led also to formation of 3c and 2b in high enantioselectivity. Single crystal X-ray diffraction established the S-configuration of (+)-cytallene (3c), thus confirming the assignment made on the basis of Lowe-Brewster rule. An improved large-scale synthesis of (+/-)-cytallene (1b) is also described. The R-enantiomer 2b inhibited the replication of a primary human immunodeficiency virus (HIV-1) isolate in phytohemagglutinin-activated peripheral blood mononuclear cells (PHA-PBM) with IC50 0.4 and IC90 1.7 microM. (+/-)-Cytallene (1b) exhibited IC50 0.8 and IC90 3.4 microM. Both compounds completely suppressed replication of HIV-1 at 10 microM with no detectable cytotoxicity. The S-enantiomer (3c) was inactive. DE Acylation Antiviral Agents/CHEMISTRY/CHEMICAL SYNTHESIS/*PHARMACOLOGY Catalysis Cells, Cultured Crystallography, X-Ray Cytosine/*ANALOGS & DERIVATIVES/CHEMISTRY/CHEMICAL SYNTHESIS/ PHARMACOLOGY Human HIV-1/*DRUG EFFECTS/PHYSIOLOGY Lipase/*METABOLISM Monocytes/VIROLOGY Stereoisomers Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Virus Replication/DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).